Report overview
This report aims to provide a comprehensive presentation of the global market for Cancer Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biomarker. This report contains market size and forecasts of Cancer Biomarker in global, including the following market information:
Global Cancer Biomarker Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Cancer Biomarker Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Cancer Biomarker companies in 2022 (%)
The global Cancer Biomarker market was valued at US$ 20140 million in 2022 and is projected to reach US$ 41530 million by 2029, at a CAGR of 10.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Protein Biomarker Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Biomarker include Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Biom?rieux SA and Merck & Co., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Biomarker manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Biomarker Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Biomarker Market Segment Percentages, by Type, 2022 (%)
Protein Biomarker
Genetic Biomarker
Global Cancer Biomarker Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Biomarker Market Segment Percentages, by Application, 2022 (%)
Diagnostics
Research
Others
Global Cancer Biomarker Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Biomarker Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Biomarker revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cancer Biomarker revenues share in global market, 2022 (%)
Key companies Cancer Biomarker sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Cancer Biomarker sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biom?rieux SA
Merck & Co.
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Quest Diagnostics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Biomarker, market overview.
Chapter 2: Global Cancer Biomarker market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Biomarker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Biomarker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Biomarker capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
